12-05-2017 07:58 AM CET - Advertising, Media Consulting, Marketing Research
Print

Global Radiopharmaceuticals Market Analysis By Procedural Volumes with Growth Rate +8.7% and Manufacturers (Cardinal Health Inc., MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging Inc., Bayer AG) Forecasts By 2024

Press release from: Data Bridge Market Research
Global Radiopharmaceuticals Market ? Industry Trends and Forecast to 2024
Global Radiopharmaceuticals Market ? Industry Trends and Forecast to 2024


Data Bridge Market Research added new industry report "Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Click Here for Sample Report Visit @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Market Segmentation:

The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.

On the basis of type, the global radiopharmaceuticals market is sub-segmented into
• Diagnostic
• Therapeutic radiopharmaceuticals.

In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into
1. Diagnostic procedure
• single-photon emission computed tomography (SPECT) radiopharmaceuticals
• positron emission tomography (PET) radiopharmaceuticals
2. Therapeutic procedures
• beta emitters
• alpha emitters
• brachy therapy

On the basis of application, the global radiopharmaceuticals market is sub-segmented into
1. diagnostic application
• single-photon emission computed tomography (SPECT) -
• positron emission tomography (PET)- oncology, cardiology, neurology and others
2. therapeutic application
• thyroid,
• bone metastasis,
• lymphoma,
• endocrine tumours
• others

On the basis of sources, the global radiopharmaceuticals market is sub-segmented into
• nuclear reactors
• cyclotrons

On the basis of end user, the global radiopharmaceuticals market is sub-segmented into
• hospitals,
• ambulatory surgical centers,
• diagnostic centers,
• cancer research institutes and
• others

In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.

Request for Table of Content of Full Report @ databridgemarketresearch.com/toc/?dbmr=global-radiopharma...

Competitive Analysis:

The global IoT healthcare market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes IoT healthcare shares for global, Europe, North America, Asia Pacific, and South America.

Major Market Competitors:

• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• CovidienPlc
• Positron Corporation
• NTP Radioisotopes Pty. Ltd.
• Advanced Medical Isotope Corporation
• Avid Radiopharmaceuticals
• Jubilant Pharma
• Actinium Pharmaceuticals Inc.,
• Among others.

Read more about Report Visit @ databridgemarketresearch.com/reports/global-radiopharmace...

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/north-america-digita...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 844717 • Views: 356
More releasesMore releases

You can edit or delete your press release here: